ES2267671T3 - Composicion farmaceutica para el tratamiento de fimosis usando corticosteroides topicos. - Google Patents

Composicion farmaceutica para el tratamiento de fimosis usando corticosteroides topicos. Download PDF

Info

Publication number
ES2267671T3
ES2267671T3 ES01272567T ES01272567T ES2267671T3 ES 2267671 T3 ES2267671 T3 ES 2267671T3 ES 01272567 T ES01272567 T ES 01272567T ES 01272567 T ES01272567 T ES 01272567T ES 2267671 T3 ES2267671 T3 ES 2267671T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
corticosteroids
composition according
percent
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01272567T
Other languages
English (en)
Spanish (es)
Inventor
Paulo Cesar Rodrigues Palma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apsen Farmaceutica SA
Original Assignee
Apsen Farmaceutica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apsen Farmaceutica SA filed Critical Apsen Farmaceutica SA
Application granted granted Critical
Publication of ES2267671T3 publication Critical patent/ES2267671T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES01272567T 2000-12-28 2001-12-13 Composicion farmaceutica para el tratamiento de fimosis usando corticosteroides topicos. Expired - Lifetime ES2267671T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose
BR0006556 2000-12-28

Publications (1)

Publication Number Publication Date
ES2267671T3 true ES2267671T3 (es) 2007-03-16

Family

ID=36686652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01272567T Expired - Lifetime ES2267671T3 (es) 2000-12-28 2001-12-13 Composicion farmaceutica para el tratamiento de fimosis usando corticosteroides topicos.

Country Status (12)

Country Link
US (1) US7666858B2 (https=)
EP (1) EP1365766B1 (https=)
JP (1) JP5095907B2 (https=)
CN (1) CN1270719C (https=)
AR (1) AR032208A1 (https=)
AU (1) AU2002221365A1 (https=)
BR (1) BR0006556A (https=)
DE (1) DE60121047T2 (https=)
ES (1) ES2267671T3 (https=)
MX (1) MXPA03005813A (https=)
RU (1) RU2279893C2 (https=)
WO (1) WO2002053137A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20070225670A1 (en) * 2006-03-14 2007-09-27 Connell Thomas J Diapers for improving male genital health and methods of using the same
CA2678038C (en) * 2007-02-15 2016-10-11 Allergan, Inc. Use of botulinum toxin and enzymes for treating bladder or prostate disorders, or hyperhydrosis
RU2635460C2 (ru) * 2010-06-17 2017-11-13 Нитто Денко Корпорейшн Средство для лечения фиброза почек
WO2012012300A2 (en) 2010-07-20 2012-01-26 Halozyme, Inc. Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects
CN102302779A (zh) * 2011-07-29 2012-01-04 岳中瑾 治疗包茎的乳膏制剂及其应用
RU2569431C2 (ru) * 2013-07-08 2015-11-27 Александр Васильевич Газаматов Способ консервативного лечения фимоза
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110314168A (zh) * 2019-07-27 2019-10-11 清远市人民医院 一种用于治疗小儿包茎的药物组合物及其制备方法
RU2730476C1 (ru) * 2019-12-24 2020-08-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Противовоспалительная мазь для животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058780C1 (ru) * 1992-11-17 1996-04-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы

Also Published As

Publication number Publication date
US7666858B2 (en) 2010-02-23
RU2003119439A (ru) 2005-02-27
US20040067922A1 (en) 2004-04-08
JP5095907B2 (ja) 2012-12-12
AR032208A1 (es) 2003-10-29
EP1365766B1 (en) 2006-06-21
MXPA03005813A (es) 2005-02-14
WO2002053137A2 (en) 2002-07-11
HK1060850A1 (en) 2004-08-27
DE60121047D1 (de) 2006-08-03
RU2279893C2 (ru) 2006-07-20
CN1487833A (zh) 2004-04-07
EP1365766A2 (en) 2003-12-03
JP2004519451A (ja) 2004-07-02
DE60121047T2 (de) 2007-06-21
AU2002221365A1 (en) 2002-07-16
WO2002053137A3 (en) 2003-04-24
BR0006556A (pt) 2002-09-17
CN1270719C (zh) 2006-08-23

Similar Documents

Publication Publication Date Title
Bell Amlexanox for the treatment of recurrent aphthous ulcers
US7112578B2 (en) Methods and compositions for treatment of inflammatory disease
ES2267671T3 (es) Composicion farmaceutica para el tratamiento de fimosis usando corticosteroides topicos.
JP2005533047A (ja) アフタ潰瘍および単純ヘルペス病変の予防および処置のための組成物および方法
JPH02501739A (ja) ステロイドローション剤
US20120022019A1 (en) Medicinal Steroids Cream And A Process To Make It
KR101642537B1 (ko) 푸시드산나트륨을 사용하고 생체중합체를 혼입한 약용 푸시드산 크림 및 이의 제조 방법
CN101208096A (zh) 氯倍他索喷雾制剂在治疗银屑病中的应用
WO2001041783A1 (en) Methods and compositions for treatment of inflammatory disease
US10960011B2 (en) Compositions for the treatment of ischemic ulcers and stretch marks
AU2015379295A1 (en) Enema for rectal application
US20170119792A1 (en) Methods and compositions for dermatological use comprising clobetasol and halobetasol and biopolymers
Boiko et al. Diagnosis and treatment of atopic dermatitis, urticaria, and angioedema during pregnancy
AU2012396941A2 (en) Use of pidotimod to treat atopic dermatitis
US20170119791A1 (en) Methods and compositions for dermatological use comprsing betamethasone and biopolymers
CA2581364A1 (en) Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations
CA2973542C (en) Enema for rectal application
HK1060850B (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
Taniguchi et al. A Novel Strategy for Umbilical Granuloma Removal: Cutting off with a Nylon Suture Thread
AU6468800A (en) Pharmaceutical composition for topical application, uses and process for the preparation thereof
Finucci et al. Clinical assessment of the activity and the tolerability of a Triticum vulgare extract-containing medical device in patients with haemorrhoids
SO Comparison of a New Medicinal Plant Extract and Triamcinolone Acetonide in Treatment of Recurrent Aphthous Stomatitis
Urbańska et al. Stevens-Johnson syndrome as a severe adverse drug reaction–
JPS61225124A (ja) 皮膚疾患用剤
HK1210938B (en) Use of pidotimod to treat atopic dermatitis